Cover Image

醫藥學術專員 (MSL) 的活動、業績的評價標準

Charting MSL Activity and Performance

出版商 FirstWord 商品編碼 226467
出版日期 內容資訊 英文 58 Pages
商品交期: 最快1-2個工作天內
Back to Top
醫藥學術專員 (MSL) 的活動、業績的評價標準 Charting MSL Activity and Performance
出版日期: 2015年06月01日 內容資訊: 英文 58 Pages

醫藥學術專員 (MSL) ,可說是現在製藥公司的「門面」,是在新藥上市時負責和醫生交涉的重要角色。可是,因為職務內容幅度寬廣,在企業方面要識別、測量MSL的附加價值創造的貢獻是困難的。除了法規的差異、變動的問題,美國和歐洲,現在與未來,評價MSL的活動內容的標準會產生差異嗎?

本報告依據美國及歐洲主要5個國家的80名著名醫藥學術專員 (以下MSL)的問卷調查,提供MSL的活動內容、企業內部對於業績的評估方法相關分析、MSL的主要活動內容和平均行動 (負責的品牌數量、跟醫生接觸機會的數量、時間等)、企業內部的評估手段、標準、各地區、各企業的差異、公司內部的利害關係者的關聯性、今後有效利用評價標準的辦法等項目。


  • 負責的品牌數量和責任的範圍
  • MSL的各品牌的負責分配,和新產品相關與醫生的討論
  • MSL的產品上市前/上市後的活動
  • 跟醫生接觸的數量與方法
  • 本人要求與對方要求間折衝交涉花費的時間


  • 公司內部的通訊的頻率與形態
  • 為了評估MSL使用的業績指標
  • 表面的價值指標相關資訊收集的方法
  • 業績評估的頻率


  • 價值證明中MSL的業績指標的可用性
  • 價值證明中MSL的業績指標的變更預測



  • 選擇標準:MSL簡介


Product Code: 596200296

A unique survey providing key insights and actionable intelligence. Access expert analysis and data analysis slides in MS PowerPoint and the full data tabulations in MS Excel.

Charting MSL Activity and Performance distils the key findings from one of the most comprehensive surveys of specialist Medical Science Liaison (MSL) personnel in the US and EU5 markets. Informed by the responses and experiences of 80 MSLs, this survey identifies critical variations in MSL activity and presents thought-provoking ideas for the improvement of MSL performance and assessment and how it might change in the future.

Medical Science Liaisons are now the most trusted face of pharma and provide a critically important communication channel with physicians in support of new brands. However, their role has diversified and companies are struggling to identify and measure key MSL outcomes that provide value. Against a background of increasing regulatory oversight, what are the main differences to be found in the US and Europe and what are the current and future approaches to performance measurement that are shaping and defining MSL activity?

Order today to gain insights on how to benchmark your MSL programme and apply engagement techniques used elsewhere.

Gain Answers to Critical Questions

  • At what drug development stage is an MSL team established, how many brands do they handle and how does this differ between the US and Europe?
  • How do MSL performance measurement criteria change pre to post launch?
  • “Building new KOL relationships” is a critical post launch activity but what outcomes are sought and how is success measured?
  • To what extent do US and European views differ on MSL activity in CME, KOL education and publication programmes?
  • What performance criteria do MSL experts see as becoming increasingly important over the near term?
  • Has the rise of new stakeholders changed the way MSL performance is measured?
  • What metrics are companies using to demonstrate MSL value to internal stakeholders?

Report Deliverables

Your report purchase gives you access to unique data and analysis that can be employed practically in your plans and briefings as well as hone your internal performance measurement systems:

  • Data Report: Clear, concise and easy to read tables and charts presented as MS PowerPoint slides with expert views on key findings
  • Data Tabulations: All the data provided in MS Excel
  • Survey Questionnaire: delivered as a PDF document

Key Takeaways

  • Understand which MSL activities are seen as being most important in the US and Europe
  • Benchmark your own MSL programme and identify new ways to improve performance
  • Understand differing US/European attitudes in key areas such payer engagement, KOL education, publication programmes and congress attendance, and challenge accepted norms
  • Examine the importance European MSLs place on training internal sales forces over their US colleagues
  • Identify the most widely used measurements for evaluating KOL engagement and feedback
  • Appreciate the current and future regulatory demands that are impacting MSL activity and prompting a rethink of priorities
  • Understand the current balance between quantitative and qualitative metrics used to measure MSL performance, and assess signals that may indicate a change in the type of metrics used in the future

Table of Contents

MSL Activities

  • Number of Brands Supported and Areas of Responsibility
  • Assignment of MSLs to Brands and Discussion of New Products with Physicians
  • MSL Pre-Launch and Post-Launch Activities
  • Numbers and Methods of Interactions With Physicians
  • Time Spent on Proactive vs. Reactive Engagement

MSL Performance Measurements

  • Internal Communication Frequency and Format
  • Performance Measurements Used to Evaluate MSLs
  • Methods to Gather Information on External Value Metrics
  • Frequency of Performance Review

Value Demonstration to Internal Stakeholders of MSL Performance Measurements

  • Usefulness of MSL Performance Measurements in Value Demonstration
  • Expected Changes in MSL Performance Measurements in Value Demonstration

Expert Analysis


  • Screeners - MSL profile
Back to Top